- Home
- RENB vs HYPR Comparison
RENB vs HYPR Comparison
Compare RENB & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- HYPR
- Stock Information
- Founded
- RENB 2011
- HYPR 2014
- Country
- RENB United States
- HYPR United States
- Employees
- RENB N/A
- HYPR N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- HYPR Medical Specialities
- Sector
- RENB Health Care
- HYPR Health Care
- Exchange
- RENB Nasdaq
- HYPR Nasdaq
- Market Cap
- RENB 57.7M
- HYPR 55.9M
- IPO Year
- RENB N/A
- HYPR N/A
- Fundamental
- Price
- RENB $0.17
- HYPR $1.45
- Analyst Decision
- RENB
- HYPR Strong Buy
- Analyst Count
- RENB 0
- HYPR 3
- Target Price
- RENB N/A
- HYPR $1.28
- AVG Volume (30 Days)
- RENB 993.7K
- HYPR 247.9K
- Earning Date
- RENB 11-13-2025
- HYPR 11-11-2025
- Dividend Yield
- RENB N/A
- HYPR N/A
- EPS Growth
- RENB N/A
- HYPR N/A
- EPS
- RENB N/A
- HYPR N/A
- Revenue
- RENB N/A
- HYPR $10,797,000.00
- Revenue This Year
- RENB N/A
- HYPR $12.92
- Revenue Next Year
- RENB N/A
- HYPR $32.10
- P/E Ratio
- RENB N/A
- HYPR N/A
- Revenue Growth
- RENB N/A
- HYPR N/A
- 52 Week Low
- RENB $0.17
- HYPR $0.53
- 52 Week High
- RENB $2.10
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- RENB 31.45
- HYPR 67.52
- Support Level
- RENB $0.18
- HYPR $1.36
- Resistance Level
- RENB $0.22
- HYPR $1.47
- Average True Range (ATR)
- RENB 0.02
- HYPR 0.08
- MACD
- RENB -0.00
- HYPR 0.02
- Stochastic Oscillator
- RENB 0.53
- HYPR 90.91
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.